NEVVI Medicare utilization intelligence
or

← back

Provider profile

DASILVA, DIEGO MD

Dermatology · NPI 1912499047 · VIRGINIA BEACH, VA

1
Groups
47
Codes · 2024
7,944
Disclosed services

DASILVA, DIEGO is a Dermatology in VIRGINIA BEACH, VA, a member of 1 medical group, who billed 47 distinct codes to Medicare Part B in 2024.

Groups: FOREFRONT DERMATOLOGY SC (PENSACOLA, FL)

Year: 2024 · 2023 · 2022 🔒

Provider overview · all codes · CY2024

7,944
disclosed services
47
codes billed to Medicare Part B
Prior year · CY2023 11,593 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17110 Destruction of skin growth, 1-14 growths
17000 Destruction of precancer skin growth, 1 growth
17004 Destruction of precancer skin growth, 15 or more growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
11102 Biopsy of related skin growth, first growth
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
11103 Biopsy of related skin growth, each additional growth
96372 Injection of drug or substance under skin or into muscle
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
11303 Shaving of skin growth of body, arms, or legs, more than 2.0 cm
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
11900 Injection into skin growth, 1-7 growths
11604 Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11901 Injection into skin growth, more than 7 growths
10060 Simple or single drainage of skin abscess
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
10061 Complicated or multiple drainage of skin abscess
13122 Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less
13102 Complicated repair of wound of trunk, each additional 5.0 cm or less
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
11623 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
96405 Administration of chemotherapy into growth, 1-7
J9190 Injection, fluorouracil, 500 mg
17106 Destruction of birthmark, less than 10.0 sq cm
11104 Punch biopsy, first skin growth
11308 Shaving of skin growth of scalp, neck, hands, feet, or genitals, more than 2.0 cm
11403 Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm
11643 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm
96567 Application of light to destroy precancer skin growth
11313 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, more than 2.0 cm
11105 Punch biopsy, each additional skin growth
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.